My understanding is that the current plant in Sydney is for smaller batches to obtain product approvals & not full scale production. Their website states:
"With a wholly owned automated manufacturing facility now established in Sydney, Recce Pharmaceuticals is well placed to produce product in volumes to support planned Phase I and Phase II clinical trials. Our Sydney facility is supported by a second manual manufacturing facility in Perth, Western Australia."
RCE Price at posting:
31.5¢ Sentiment: Hold Disclosure: Held
